000 07930cam a22007938i 4500
001 on1042077388
003 OCoLC
005 20201009115341.0
006 m o d
007 cr |n|||||||||
008 180619s2018 nju ob 001 0 eng
010 _a 2018029534
040 _aDLC
_beng
_erda
_cDLC
_dOCLCO
_dOCLCF
_dN$T
_dEBLCP
_dUIU
_dDG1
_dMERER
_dUKMGB
_dOTZ
_dOCLCQ
066 _c(S
015 _aGBB8I6276
_2bnb
016 7 _a019080867
_2Uk
019 _a1054128975
020 _a9781119312307
_q(ePub)
020 _a1119312302
_q(ePub)
020 _a9781119312321
_q(electronic bk. : oBook)
020 _a1119312329
_q(electronic bk. : oBook)
020 _z9781119312284
_q(hardback)
020 _z1119312280
_q(hardback)
020 _a9781119312291
_q(electronic bk.)
020 _a1119312299
_q(electronic bk.)
029 1 _aUKMGB
_b019080867
029 1 _aCHVBK
_b549244638
029 1 _aCHNEW
_b001025653
035 _a(OCoLC)1042077388
_z(OCoLC)1054128975
037 _a9781119312307
_bWiley
042 _apcc
050 1 0 _aRA1238
072 7 _aMED
_x071000
_2bisacsh
082 0 0 _a615.9/02
_223
084 _aSCI013040
_aTEC010010
_2bisacsh
049 _aMAIN
100 1 _aJjemba, Patrick K.,
_eauthor.
245 1 0 _aPharma-ecology :
_bthe occurrence and fate of pharmaceuticals and personal care products in the environment /
_cPatrick K. Jjemba.
250 _aSecond edition.
263 _a1811
264 1 _aHoboken, NJ :
_bWiley,
_c[2018]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
520 _a"This book links the health and environmental sciences professions; concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment. Knowledge about the ecological impact of PPCPs is dynamically changing as better and more sensitive detection techniques become available, and new information has come up since the book first published. This new edition brings the readership up-to-date and continues to bridge the gap between medicine / public health and environmental science. It is an approach that arouses interest in the topic among health-care providers, engineers, toxicologists, pharmacists, ecologists, microbiologists, chemists, and policy makers. Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice Updates information on PPCPs ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter"--
_cProvided by publisher.
520 _a"Sales handles: - Links the health and environmental sciences professions' concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment - Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed - Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice - Updates information on PPCPs' ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter Bridges the gap between medicine / public health and environmental science Market description: Engineers, toxicologists, ecologists, microbiologists, chemists involved in pollution and environmental analysis. Regulatory agencies like the EPA or FDA, which are concerned with the potential negative impacts of pharmaceutical products and waste. Pharmaceutical professionals who design and develop pharmaceutical and personal care products (PPCPs) and who need to understand how they impact the environment"--
_cProvided by publisher.
504 _aIncludes bibliographical references and index.
588 0 _aPrint version record and CIP data provided by publisher; resource not viewed.
505 0 _aIntro; Title Page; Copyright Page; Contents; Preface; Chapter 1 Usage of Pharmaceutical and Personal Care Products; 1.1 Pharmaceutical Consumption Trends; Study Questions; References; Chapter 2 Most Prescribed Pharmaceuticals and Related Endpoints; 2.1 Antihypertensive and Cardiovascular; 2.2 Anxiolytic Sedatives, Hypnotics, and Antipsychotics; 2.3 Analgesics and Anti-inflammatory Drugs; Study Questions; References; Chapter 3 Usage of Antimicrobial Agents and Related Endpoints; 3.1 Cell Wall Synthesis Inhibiting Antibiotics; 3.2 Inhibitors of Protein Synthesis
505 8 _a3.3 Nucleic Acid Synthesis Inhibitors3.4 Antagonism to Metabolic Processes; 3.5 Antibiotics that Disrupt Membrane Integrity; 3.6 Other Antimicrobials; Study Questions; References; Chapter 4 Usage of Other Groups of Pharmaceuticals and Related Endpoints; 4.1 Gastrointestinal Drugs; 4.2 Antidiabetic Drugs; 4.3 Diuretics and Electrolytes; 4.4 Thyroid System Medication; 4.5 Respiratory Drugs; 4.6 Oral Contraceptive and Reproductive Therapeutics; 4.7 Biophosphonates and Other Skeletal Ailment Drugs; 4.8 Steroids; 4.9 Hematologic Drugs; 4.10 Nutritional Drugs; 4.11 Triptans; 4.12 Anesthetics
505 8 _a4.13 Antineoplastics and ImmunosuppressantsStudy Questions; References; Chapter 5 Personal Care Products of Environmental Concern; 5.1 Fragrances and Musks; 5.2 Ultraviolet Light Filters; 5.3 Detergents; 5.4 Disinfectants; Study Questions; References; Chapter 6 Detection and Occurrence of PPCPs in the Environment; 6.1 Detection of PPCPs in the Environment; 6.1.1 Detection Using Instrumentation; 6.1.2 Detection Using Bioassays; 6.2 Occurrence of PPCPs in Various Environments; 6.2.1 Aquatic Systems; 6.2.1.1 PPCPs in Wastewater; 6.2.1.2 PPCPs in Surface Water; 6.2.1.3 PPCPs in Groundwater
505 8 _a6.2.1.4 PPCPs in Potable Water6.2.2 Occurrence of PPCPs in Sediments; 6.2.3 Occurrence of PPCPs in Soil; 6.2.4 PPCPs in Aerial Environments; 6.3 Excretion as a Driver of Pharmaceutical Occurrence in the Environment; Study Questions; References; Chapter 7 Ecopharmacokinetics and Ecopharmacodynamics of PPCPs; 7.1 Overview of Pharmacokinetics and Pharmacodynamics; 7.1.1 PPCP Sorption and Bioavailability in the Environment; 7.1.2 Compound Half-life and Clearance; 7.2 Degradation of PPCPs in the Environment; 7.2.1 Degradation of Antibiotics in the Environment
650 0 _aDrugs
_xToxicology.
650 0 _aHygiene products
_xToxicology.
650 0 _aDrugs
_xEnvironmental aspects.
650 0 _aHygiene products
_xEnvironmental aspects.
650 0 _aEnvironmental toxicology.
650 7 _aSCIENCE / Chemistry / Organic.
_2bisacsh
650 7 _aTECHNOLOGY & ENGINEERING / Environmental / Pollution Control.
_2bisacsh
650 7 _aDrugs
_xToxicology.
_2fast
_0(OCoLC)fst00898958
650 7 _aEnvironmental toxicology.
_2fast
_0(OCoLC)fst00913536
650 7 _aMEDICAL / Pharmacology
_2bisacsh
655 4 _aElectronic books.
776 0 8 _iPrint version:
_aJjemba, Patrick K., author.
_tPharma-ecology
_bSecond edition.
_dHoboken, NJ : Wiley, [2018]
_z9781119312284
_w(DLC) 2018027837
856 4 0 _uhttps://doi.org/10.1002/9781119312321
_zWiley Online Library
880 8 _6505-00/(S
_a7.2.1.1 Degradation of Quinolone Compounds7.2.1.2 Fate of β-Lactams and Cephalosporins; 7.2.1.3 Degradation of Tetracyclines; 7.2.1.4 Degradation of Macrolides; 7.2.1.5 Fate of Other Important Groups of Antibiotics; 7.2.2 Degradation of Analgesics and Anti-inflammatory Drugs; 7.2.3 Degradation of Estrogens and Other Reproductive Hormones; 7.2.4 Degradation of Other Important Pharmaceuticals; 7.2.5 Degradation of Surfactants; 7.3 Role of Physicochemical Factors in the Fate of PPCPs in the Environment; 7.3.1 Molecular Size as an Attribute to Absorption and Persistence
994 _a92
_bDG1
999 _c79110
_d79110